A precision medicine approach for psychiatric disease based on repeated symptom scores.
暂无分享,去创建一个
Scott L Zeger | P. Zandi | S. Zeger | A. Fojo | Peter P Zandi | K. Musliner | Anthony T Fojo | Katherine L Musliner
[1] Elizabeth L. Ogburn,et al. Statistical Reasoning and Methods in Epidemiology to Promote Individualized Health: In Celebration of the 100th Anniversary of the Johns Hopkins Bloomberg School of Public Health. , 2016, American journal of epidemiology.
[2] S. Marder,et al. Risperidone in the treatment of schizophrenia. , 1994, The American journal of psychiatry.
[3] Elisa T. Lee,et al. Statistical Methods for Survival Data Analysis , 1994, IEEE Transactions on Reliability.
[4] H. Krumholz. Big data and new knowledge in medicine: the thinking, training, and tools needed for a learning health system. , 2014, Health affairs.
[5] Graeme L. Hickey,et al. Joint Modelling of Multivariate Longitudinal Data and Time-to-Event Outcomes , 2016 .
[6] Ewout W Steyerberg,et al. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.
[7] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[8] R. Spitzer,et al. The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.
[9] Katherine E. Masyn,et al. New approaches to studying problem behaviors: a comparison of methods for modeling longitudinal, categorical adolescent drinking data. , 2009, Developmental psychology.
[10] B. Druss,et al. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. , 2015, JAMA psychiatry.
[11] P. Zandi,et al. Heterogeneity in long-term trajectories of depressive symptoms: Patterns, predictors and outcomes. , 2016, Journal of affective disorders.
[12] Roy H Perlis,et al. Abandoning personalization to get to precision in the pharmacotherapy of depression , 2016, World psychiatry : official journal of the World Psychiatric Association.
[13] A Labelle,et al. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. , 1993, Journal of clinical psychopharmacology.
[14] B. Löwe,et al. Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population , 2008, Medical care.
[15] Graeme L. Hickey,et al. Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues , 2016, BMC Medical Research Methodology.
[16] S. R. Searle,et al. Generalized, Linear, and Mixed Models , 2005 .
[17] D. Rubin,et al. Inference from Iterative Simulation Using Multiple Sequences , 1992 .
[18] Conor V. Dolan,et al. Factor analysis of variables with 2, 3, 5, and 7 response categories: A comparison of categorical variable estimators using simulated data , 1994 .
[19] Scott L. Zeger,et al. Generalized linear models with random e ects: a Gibbs sampling approach , 1991 .
[20] E. Ziegel. Statistical Methods for Survival Data Analysis , 1993 .
[21] E. Ashley. Towards precision medicine , 2016, Nature Reviews Genetics.
[22] F. Collins,et al. A new initiative on precision medicine. , 2015, The New England journal of medicine.
[23] M. Karim. Generalized Linear Models With Random Effects , 1991 .
[24] Suchi Saria,et al. A Framework for Individualizing Predictions of Disease Trajectories by Exploiting Multi-Resolution Structure , 2015, NIPS.
[25] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.
[26] J. Weiner,et al. Morbidity Trajectories as Predictors of Utilization: Multi-year Disease Patterns in Taiwan's National Health Insurance Program , 2011, Medical care.
[27] K. Wardenaar,et al. Symptom-specific course trajectories and their determinants in primary care patients with Major Depressive Disorder: Evidence for two etiologically distinct prototypes. , 2015, Journal of affective disorders.
[28] David B. Dunson,et al. Bayesian Data Analysis , 2010 .
[29] K. McLaughlin,et al. Developmental Trajectories of Anxiety and Depression in Early Adolescence , 2014, Journal of Abnormal Child Psychology.
[30] G. Remington,et al. Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia. , 2011, The British journal of psychiatry : the journal of mental science.
[31] T. Vos,et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.
[32] P. Diggle,et al. Analysis of Longitudinal Data , 2003 .
[33] W. Tschacher,et al. Symptom trajectories in psychotic episodes. , 2002, Comprehensive psychiatry.
[34] R. Spitzer,et al. The PHQ-9 , 2001, Journal of General Internal Medicine.
[35] H. Krumholz. For A Learning Health System Big Data And New Knowledge In Medicine: The Thinking, Training, And Tools Needed , 2014 .